These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34001440)

  • 1. Factors Associated With Surgical Modality Following Neoadjuvant Chemotherapy in Patients with Breast Cancer.
    Li X; Yan C; Xiao J; Xu X; Li Y; Wen X; Wei H
    Clin Breast Cancer; 2021 Oct; 21(5):e611-e617. PubMed ID: 34001440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy.
    Kantor O; Ajmani G; Wang CH; Datta A; Yao K
    Ann Surg Oncol; 2018 Jan; 25(1):164-172. PubMed ID: 29127538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rising Bilateral Mastectomy Rates Among Neoadjuvant Chemotherapy Recipients in California From 1998 to 2012.
    Wapnir IL; Kurian AW; Lichtensztajn DY; Clarke CA; Gomez SL
    Ann Surg; 2017 Aug; 266(2):353-360. PubMed ID: 27611617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-doctoral factors influencing the surgical choice of Chinese patients with breast cancer who were eligible for breast-conserving surgery.
    Chen R; You S; Yin Z; Zhu Q; Jiang C; Li S; Li Y; Zha X; Wang J
    World J Surg Oncol; 2019 Nov; 17(1):189. PubMed ID: 31711515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study.
    Simons JM; Jacobs JG; Roijers JP; Beek MA; Boonman-de Winter LJM; Rijken AM; Gobardhan PD; Wijsman JH; Tetteroo E; Heijns JB; Yick CY; Luiten EJT
    Breast Cancer Res Treat; 2021 Jan; 185(2):441-451. PubMed ID: 33073303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of breast-conserving surgery with mastectomy in locally advanced breast cancer after good response to neoadjuvant chemotherapy: A PRISMA-compliant systematic review and meta-analysis.
    Sun Y; Liao M; He L; Zhu C
    Medicine (Baltimore); 2017 Oct; 96(43):e8367. PubMed ID: 29069026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit.
    Spronk PER; Volders JH; van den Tol P; Smorenburg CH; Vrancken Peeters MTFD
    Eur J Surg Oncol; 2019 Feb; 45(2):110-117. PubMed ID: 30348601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?
    Mamtani A; Sevilimedu V; Le T; Morrow M; Barrio AV
    Cancer; 2022 Feb; 128(3):471-478. PubMed ID: 34597420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present and changing trends in surgical modalities and neoadjuvant chemotherapy administration for female breast cancer in Beijing, China: A 10-year (2006-2015) retrospective hospitalization summary report-based study.
    Bao X; Sun K; Tian X; Yin Q; Jin M; Yu N; Jiang H; Zhang J; Hu Y
    Thorac Cancer; 2018 Jun; 9(6):707-717. PubMed ID: 29624915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study.
    Puig CA; Hoskin TL; Day CN; Habermann EB; Boughey JC
    Ann Surg Oncol; 2017 May; 24(5):1242-1250. PubMed ID: 28000076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is mastectomy with immediate reconstruction safe for patients undergoing neoadjuvant chemotherapy? A nationwide study from Korean Breast Cancer Society.
    Park S; Jeong J; Han W; Lee YJ; Kim HA; Lee S; Do Byun K; Choi YJ; Kim J; Bae SY
    Breast Cancer; 2021 Jul; 28(4):874-883. PubMed ID: 33586091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy for stage II-III breast cancer: a single-center experience.
    Zaher HAE; Fathy H; Abozeid M; Faisal M
    World J Surg Oncol; 2023 Oct; 21(1):314. PubMed ID: 37805553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting locoregional recurrence in breast cancer patients undergoing surgery following neoadjuvant treatment.
    Chou HH; Chung WS; Ding RY; Kuo WL; Yu CC; Tsai HP; Shen SC; Chu CH; Lo YF; Chen SC
    BMC Surg; 2021 Mar; 21(1):160. PubMed ID: 33757489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: A multicenter real-world study (CSBrS-012).
    Li Y; Chen H; He J; Fan Z; Zhang H
    Front Public Health; 2023; 11():1100421. PubMed ID: 36895689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of breast imaging parameters obtained from
    Grapin M; Coutant C; Riedinger JM; Ladoire S; Brunotte F; Cochet A; Humbert O
    Eur J Radiol; 2019 Apr; 113():81-88. PubMed ID: 30927964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer.
    Man VC; Cheung PS
    Hong Kong Med J; 2017 Jun; 23(3):251-7. PubMed ID: 28484080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy.
    Gulis K; Ellbrant J; Svensjö T; Skarping I; Vallon-Christersson J; Loman N; Bendahl PO; Rydén L
    Eur J Surg Oncol; 2023 Jul; 49(7):1189-1195. PubMed ID: 37019807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients.
    Shin HC; Han W; Moon HG; Im SA; Moon WK; Park IA; Park SJ; Noh DY
    Ann Surg Oncol; 2013 Aug; 20(8):2582-9. PubMed ID: 23504119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
    Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
    J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of the multidisciplinary team in the decision-making process of patients undergoing neoadjuvant chemotherapy for breast cancer.
    Fancellu A; Pasqualitto V; Cottu P; Giuliani G; Grasso L; Ariu ML; Porcu A; Sanna V
    Updates Surg; 2024 Sep; 76(5):1919-1926. PubMed ID: 38315320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.